医学
甘精胰岛素
磺酰脲
二甲双胍
2型糖尿病
内科学
兴奋剂
糖尿病
内分泌学
胰岛素
受体
作者
Stefano Del Prato,Steven E. Kahn,Imre Pávó,Govinda Weerakkody,Zhengyu Yang,John Doupis,Diego Aizenberg,Alan G. Wynne,Jeffrey S. Riesmeyer,Robert J. Heine,Russell J. Wiese,Jochen Seufert
出处
期刊:Diabetologie Und Stoffwechsel
[Georg Thieme Verlag KG]
日期:2022-05-01
被引量:6
标识
DOI:10.1055/s-0042-1746267
摘要
Background Efficacy and safety of novel dual GIP/GLP-1 receptor agonist tirzepatide versus insulin glargine was assessed in adults with type 2 diabetes inadequately controlled on metformin, sulfonylurea, and/or SGLT-2i and increased cardiovascular risk.
科研通智能强力驱动
Strongly Powered by AbleSci AI